Stock Events

Stock Events

Processa Pharmaceuticals 

$2.16
63
+$0.06+2.65% 18:08 Today

Statistics

Day High
2.18
Day Low
2.11
52W High
14.25
52W Low
1.67
Volume
16,232
Avg. Volume
252,612
Mkt Cap
7.23M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29OctExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
Next
-2
-1.41
-0.81
-0.22
Expected EPS
-1
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-13.56MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PCSA. It's not an investment recommendation.
NVIDIA
11
NVDA
Amazon
9
AMZN
Apple
8
AAPL
Microsoft
8
MSFT

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap171.56B
Gilead Sciences focuses on developing drugs for critical diseases, similar to Processa's focus on unmet medical needs, making them direct competitors in the pharmaceutical market.
AMGEN
AMGN
Mkt Cap224.63B
Amgen develops innovative human therapeutics, including treatments for serious illnesses, competing with Processa Pharmaceuticals in the biopharmaceutical sector.
Pfizer
PFE
Mkt Cap152.69B
Pfizer is involved in the discovery, development, and manufacture of healthcare products, including medicines and vaccines, competing with Processa in the pharmaceuticals market.
Merck
MRK
Mkt Cap335.14B
Merck operates in the pharmaceutical industry, focusing on drugs for conditions with significant unmet needs, directly competing with Processa Pharmaceuticals.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie is a research-based biopharmaceutical company with a similar focus on serious diseases, making it a competitor to Processa Pharmaceuticals.
Bristol-Myers Squibb
BMY
Mkt Cap130.39B
Bristol Myers Squibb is a global biopharmaceutical company focusing on discovering, developing, and delivering innovative medicines, competing with Processa in the area of serious and life-threatening diseases.
Regeneron Pharmaceuticals
REGN
Mkt Cap82.72B
Regeneron Pharmaceuticals is known for its innovative drug development, particularly in areas of high unmet medical need, positioning it as a competitor to Processa.
Vertex Pharmaceuticals
VRTX
Mkt Cap128.19B
Vertex Pharmaceuticals focuses on creating new possibilities in medicine to cure diseases and improve people's lives, competing with Processa in the pharmaceutical innovation sector.
Novartis
NVS
Mkt Cap286.78B
Novartis focuses on patented medicines, generics, and biosimilars, with a strong emphasis on research and development, making it a competitor to Processa Pharmaceuticals.
Astrazeneca
AZN
Mkt Cap242.64B
AstraZeneca operates in the pharmaceutical and biopharmaceutical market, focusing on the development of new medicines, directly competing with Processa Pharmaceuticals in the area of addressing unmet medical needs.

About

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The four NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS11T, also referred to as NGC-Iri, is an analog of SN38, and PCS11T, PCS12852, and PCS499.
Show more...
CEO
George K. Ng
Employees
12
Country
United States
ISIN
US74275C4033

Listings

BOATS
BOATS
PCSA.BOATS
XNAS
US
PCSA

0 Comments

Share your thoughts

FAQ

What is Processa Pharmaceuticals stock price today?▼
The current price of PCSA is $2.16 USD — it has increased by +2.65% in the past 24 hours. Watch Processa Pharmaceuticals stock price performance more closely on the chart.
What is Processa Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Processa Pharmaceuticals stocks are traded under the ticker PCSA.
Is Processa Pharmaceuticals stock price growing?▼
PCSA stock has fallen by -15.62% compared to the previous week, the month change is a -6.49% fall, over the last year Processa Pharmaceuticals has showed a -58.16% decrease.
What is Processa Pharmaceuticals market cap?▼
Today Processa Pharmaceuticals has the market capitalization of 7.23M
When is the next Processa Pharmaceuticals earnings date?▼
Processa Pharmaceuticals is going to release the next earnings report on October 29, 2026.
What is Processa Pharmaceuticals revenue for the last year?▼
Processa Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Processa Pharmaceuticals net income for the last year?▼
PCSA net income for the last year is -13.56M USD.
How many employees does Processa Pharmaceuticals have?▼
As of August 19, 2026, the company has 12 employees.
In which sector is Processa Pharmaceuticals located?▼
Processa Pharmaceuticals operates in the Health & Wellness sector.
When did Processa Pharmaceuticals complete a stock split?▼
The last stock split for Processa Pharmaceuticals was on December 17, 2025 with a ratio of 1:25.
Where is Processa Pharmaceuticals headquartered?▼
Processa Pharmaceuticals is headquartered in VERO BEACH, United States.